by Nordic Pharma | Mar 9, 2017 | News
March 1, 2017 Amring Pharmaceuticals Inc. acquired six ANDA’s from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture between Luitpold Pharmaceuticals, Inc. and Alphagen Laboratories Inc. The acquired ANDAs include niche otic and ophthalmic...
by Mike H | Apr 29, 2016 | News
April 29, 2016 Amring Pharmaceuticals Inc. and Integrated Commercialization Solutions Inc. (ICS) have agreed to expand the current list of provided services to include Account Receivables and Cash Applications. This consolidates the order to cash process to one...
by Mike H | Apr 7, 2016 | News
April 7, 2016 Amring Pharmaceuticals Inc. begins shipping Desmopressin Acetate Solution 0.01% Nasal Spray, authorized generic to Ferring Pharmaceuticals’ DDAV
by Mike H | Mar 14, 2016 | News
March 14, 2016 Amring Pharmaceuticals Inc. begins shipping Tranexamic Acid Tablets 650mg Tablets, authorized generic to Ferring Pharmaceuticals’ Lysteda®
by Mike H | Jan 25, 2016 | News
January 25, 2016 Amring Pharmaceuticals Inc. begins shipping Desmopressin Acetate Solution 10mcg/1mL Injection available in 10mL multi‐dose vials and 1mL ampules, authorized generic to Ferring Pharmaceuticals’ DDAVP®
by Mike H | Dec 14, 2015 | News
December 14, 2015 Amring Pharmaceuticals Inc. goes commercial and ships their first units of Desmopressin Acetate Tablets, authorized generic to Ferring Pharmaceuticals’ DDAVP®
Recent Comments